Increased High Molecular Weight FGF2 in Endocrine-Resistant Breast Cancer

Endocrine resistance may develop as a consequence of enhanced growth factor signaling. Fibroblast growth factor 2 (FGF2) consists of a low and several high molecular weight forms (HMW-FGF2). We previously demonstrated that antiprogestin-resistant mammary carcinomas display lower levels of progestero...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Horm Cancer
Main Authors: Sahores, Ana, Figueroa, Virginia, May, María, Liguori, Marcos, Rubstein, Adrián, Fuentes, Cynthia, Jacobsen, Britta M., Elía, Andrés, Rojas, Paola, Sequeira, Gonzalo R., Álvarez, Michelle M., González, Pedro, Gass, Hugo, Hewitt, Stephen, Molinolo, Alfredo, Lanari, Claudia, Lamb, Caroline A.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2018
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8054767/
https://ncbi.nlm.nih.gov/pubmed/29956066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12672-018-0339-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados